|
2025
|
Invention
|
Potent asgpr-binding compounds for the degradation of immunoglobulins and other proteins.
Extrac... |
|
|
Invention
|
Asgpr-binding compounds for the degradation of extracellular proteins.
Compounds and composition... |
|
2024
|
Invention
|
Apob degrading compounds and uses thereof. This invention provides apoB degrading compounds, comp... |
|
|
Invention
|
Asgpr-binding compounds for the delivery of oligonucleotides. This invention provides Therapeutic... |
|
|
Invention
|
Asgpr-binding compounds for the degradation of extracellular proteins. Compounds and compositions... |
|
|
Invention
|
Mannose 6-phosphate receptor binding compounds for the degradation of extracellular proteins. Com... |
|
|
Invention
|
Potent asgpr-binding compounds for the degradation of immunoglobulins and other proteins. Extrace... |
|
|
Invention
|
Mannose 6-phosphate or asgpr receptor binding compounds for the degradation of extracellular prot... |
|
2023
|
Invention
|
Asgpr-binding heterobifunctional compounds for the degradation of immunoglobulins. Extracellular ... |
|
|
P/S
|
Research and development in the field of pharmaceutical preparations that bind to asialoglycoprot... |
|
|
P/S
|
Research and development in the field of pharmaceutical preparations that bind to mannose 6-phosp... |
|
2022
|
Invention
|
Methods to reduce adverse effects of gene or biologics therapy. This invention provides methods t... |
|
|
Invention
|
Potent asgpr-binding compounds for the degradation of immunoglobulins and other proteins. in vivo... |
|
|
P/S
|
Pharmaceutical research and development |
|
|
P/S
|
Research and development in the field of pharmaceuticals targeting diseases mediated by extracell... |
|
2021
|
P/S
|
Pharmaceutical preparations for the treatment of immunoglogical, neurological, and metabolic dise... |
|
|
Invention
|
In vivo assembly of asgpr binding therapeutics. in vivoin vivoin vivo to treat disorders mediated... |
|
|
Invention
|
Asgpr-binding compounds for the degradation of extracellular proteins. in vivo in vivo to treat d... |
